Clifford Chance has advised Eurazeo Investment Manager on the financing granted to the international private equity fund Keensight Capital for the acquisition of Inke, a Spanish company leader in micronization of complex Active Pharmaceutical Ingredients (
Tags :Neuraxpharm
Clifford Chance has advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical company Inke to private equity firm Keensight Capital,
